| cellular protein catabolic process | GO:0044257 | 4 | 0.267 | |
| cellular macromolecule metabolic process | GO:0044260 | 391 | 0.181 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 3 | 0.137 | |
| larval development | GO:0002164 | 2 | 0.115 | |
| b cell differentiation | GO:0030183 | 1 | 0.090 | |
| lipid storage | GO:0019915 | 1 | 0.078 | |
| regulation of signal transduction | GO:0009966 | 225 | 0.068 | |
| embryo development ending in birth or egg hatching | GO:0009792 | 271 | 0.063 | |
| myeloid cell differentiation | GO:0030099 | 86 | 0.063 | |
| modification dependent protein catabolic process | GO:0019941 | 3 | 0.062 | |
| cellular protein metabolic process | GO:0044267 | 129 | 0.056 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 3 | 0.056 | |
| er nucleus signaling pathway | GO:0006984 | 2 | 0.050 | |
| protein metabolic process | GO:0019538 | 183 | 0.049 | |
| response to organic substance | GO:0010033 | 153 | 0.048 | |
| immune system development | GO:0002520 | 191 | 0.047 | |
| cellular monovalent inorganic cation homeostasis | GO:0030004 | 2 | 0.046 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 3 | 0.046 | |
| proteasomal protein catabolic process | GO:0010498 | 2 | 0.046 | |
| endoplasmic reticulum unfolded protein response | GO:0030968 | 2 | 0.046 | |
| cellular component morphogenesis | GO:0032989 | 336 | 0.044 | |
| erythrocyte differentiation | GO:0030218 | 54 | 0.041 | |
| maintenance of location | GO:0051235 | 4 | 0.040 | |
| nuclear transport | GO:0051169 | 4 | 0.040 | |
| endosomal transport | GO:0016197 | 2 | 0.038 | |
| signal transduction | GO:0007165 | 455 | 0.038 | |
| locomotion | GO:0040011 | 313 | 0.038 | |
| centrosome cycle | GO:0007098 | 1 | 0.037 | |
| regulation of organelle assembly | GO:1902115 | 4 | 0.036 | |
| regulation of nucleoside metabolic process | GO:0009118 | 2 | 0.035 | |
| negative regulation of protein phosphorylation | GO:0001933 | 4 | 0.035 | |
| regulation of nucleobase containing compound metabolic process | GO:0019219 | 250 | 0.034 | |
| gtp metabolic process | GO:0046039 | 4 | 0.034 | |
| hemopoiesis | GO:0030097 | 183 | 0.031 | |
| centrosome organization | GO:0051297 | 1 | 0.031 | |
| lysosomal transport | GO:0007041 | 2 | 0.029 | |
| b cell activation | GO:0042113 | 2 | 0.029 | |
| cellular response to topologically incorrect protein | GO:0035967 | 2 | 0.029 | |
| regulation of cellular metabolic process | GO:0031323 | 320 | 0.028 | |
| heterocycle metabolic process | GO:0046483 | 290 | 0.027 | |
| single organism organelle organization | GO:1902589 | 199 | 0.026 | |
| regulation of intracellular ph | GO:0051453 | 1 | 0.026 | |
| organelle fusion | GO:0048284 | 3 | 0.025 | |
| single organism membrane fusion | GO:0044801 | 2 | 0.025 | |
| positive regulation of signal transduction | GO:0009967 | 56 | 0.025 | |
| cell morphogenesis | GO:0000902 | 289 | 0.024 | |
| intestinal cholesterol absorption | GO:0030299 | 2 | 0.024 | |
| response to transition metal nanoparticle | GO:1990267 | 28 | 0.024 | |
| single organism localization | GO:1902578 | 225 | 0.024 | |
| aging | GO:0007568 | 2 | 0.024 | |
| neuron differentiation | GO:0030182 | 353 | 0.023 | |
| regulation of signaling | GO:0023051 | 235 | 0.023 | |
| cell part morphogenesis | GO:0032990 | 246 | 0.023 | |
| hematopoietic or lymphoid organ development | GO:0048534 | 191 | 0.022 | |
| regulation of gene expression | GO:0010468 | 265 | 0.022 | |
| regulation of multicellular organism growth | GO:0040014 | 4 | 0.022 | |
| regulation of programmed cell death | GO:0043067 | 101 | 0.022 | |
| guanosine containing compound metabolic process | GO:1901068 | 4 | 0.021 | |
| cellular response to starvation | GO:0009267 | 1 | 0.021 | |
| regulation of cellular protein catabolic process | GO:1903362 | 1 | 0.021 | |
| microtubule organizing center organization | GO:0031023 | 1 | 0.021 | |
| heme metabolic process | GO:0042168 | 9 | 0.021 | |
| actomyosin structure organization | GO:0031032 | 53 | 0.021 | |
| response to unfolded protein | GO:0006986 | 2 | 0.021 | |
| heterocycle biosynthetic process | GO:0018130 | 215 | 0.021 | |
| guanosine containing compound catabolic process | GO:1901069 | 2 | 0.020 | |
| negative regulation of cellular process | GO:0048523 | 283 | 0.020 | |
| nucleocytoplasmic transport | GO:0006913 | 4 | 0.020 | |
| amine metabolic process | GO:0009308 | 2 | 0.020 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 107 | 0.019 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 2 | 0.019 | |
| single organism metabolic process | GO:0044710 | 217 | 0.019 | |
| regulation of molecular function | GO:0065009 | 70 | 0.019 | |
| cellular localization | GO:0051641 | 97 | 0.019 | |
| plasma membrane repair | GO:0001778 | 2 | 0.019 | |
| anterior posterior pattern specification | GO:0009952 | 152 | 0.019 | |
| natural killer cell mediated immunity | GO:0002228 | 1 | 0.019 | |
| response to chemical | GO:0042221 | 320 | 0.019 | |
| porphyrin containing compound biosynthetic process | GO:0006779 | 8 | 0.018 | |
| regulation of metabolic process | GO:0019222 | 359 | 0.018 | |
| cellular biosynthetic process | GO:0044249 | 286 | 0.018 | |
| regulation of rna biosynthetic process | GO:2001141 | 213 | 0.018 | |
| cellular macromolecule biosynthetic process | GO:0034645 | 224 | 0.018 | |
| gtp catabolic process | GO:0006184 | 2 | 0.018 | |
| i kappab kinase nf kappab signaling | GO:0007249 | 4 | 0.018 | |
| morphogenesis of an epithelium | GO:0002009 | 333 | 0.018 | |
| regulation of proteolysis involved in cellular protein catabolic process | GO:1903050 | 1 | 0.018 | |
| regulation of epithelial cell proliferation | GO:0050678 | 3 | 0.018 | |
| negative regulation of epithelial cell proliferation | GO:0050680 | 1 | 0.018 | |
| regulation of macromolecule biosynthetic process | GO:0010556 | 225 | 0.018 | |
| cellular response to unfolded protein | GO:0034620 | 2 | 0.018 | |
| death | GO:0016265 | 121 | 0.017 | |
| establishment of protein localization to organelle | GO:0072594 | 4 | 0.017 | |
| negative regulation of response to cytokine stimulus | GO:0060761 | 2 | 0.017 | |
| tetrapyrrole metabolic process | GO:0033013 | 10 | 0.017 | |
| cellular component assembly | GO:0022607 | 170 | 0.017 | |
| cellular respiration | GO:0045333 | 3 | 0.017 | |
| regulation of transcription dna templated | GO:0006355 | 213 | 0.017 | |
| regulation of cell communication | GO:0010646 | 232 | 0.017 | |
| organonitrogen compound metabolic process | GO:1901564 | 74 | 0.017 | |
| protein import | GO:0017038 | 3 | 0.017 | |
| protein targeting to nucleus | GO:0044744 | 3 | 0.017 | |
| positive regulation of response to stimulus | GO:0048584 | 80 | 0.017 | |
| vacuolar transport | GO:0007034 | 2 | 0.016 | |
| multicellular organism growth | GO:0035264 | 4 | 0.016 | |
| regulation of cellular macromolecule biosynthetic process | GO:2000112 | 222 | 0.016 | |
| regulation of protein ubiquitination | GO:0031396 | 3 | 0.016 | |
| growth | GO:0040007 | 174 | 0.016 | |
| programmed cell death | GO:0012501 | 119 | 0.016 | |
| rna biosynthetic process | GO:0032774 | 181 | 0.016 | |
| protein localization to plasma membrane | GO:0072659 | 1 | 0.016 | |
| cytokinesis | GO:0000910 | 3 | 0.015 | |
| nucleic acid metabolic process | GO:0090304 | 244 | 0.015 | |
| rna metabolic process | GO:0016070 | 219 | 0.015 | |
| chromosome organization involved in meiosis | GO:0070192 | 1 | 0.015 | |
| regulation of cellular ph | GO:0030641 | 1 | 0.015 | |
| negative regulation of protein kinase activity | GO:0006469 | 4 | 0.015 | |
| myeloid cell homeostasis | GO:0002262 | 56 | 0.015 | |
| regulation of primary metabolic process | GO:0080090 | 311 | 0.015 | |
| cellular nitrogen compound biosynthetic process | GO:0044271 | 218 | 0.015 | |
| mitochondrion organization | GO:0007005 | 4 | 0.015 | |
| phagocytosis | GO:0006909 | 3 | 0.015 | |
| regulation of response to stimulus | GO:0048583 | 269 | 0.015 | |
| leukocyte mediated cytotoxicity | GO:0001909 | 1 | 0.015 | |
| positive regulation of cell cycle | GO:0045787 | 3 | 0.015 | |
| membrane fusion | GO:0061025 | 2 | 0.015 | |
| aromatic compound biosynthetic process | GO:0019438 | 217 | 0.015 | |
| axonogenesis | GO:0007409 | 152 | 0.015 | |
| positive regulation of cytokine production | GO:0001819 | 2 | 0.015 | |
| immune system process | GO:0002376 | 241 | 0.015 | |
| regulation of gtpase activity | GO:0043087 | 2 | 0.015 | |
| cellular component biogenesis | GO:0044085 | 178 | 0.014 | |
| response to copper ion | GO:0046688 | 13 | 0.014 | |
| protein modification process | GO:0036211 | 100 | 0.014 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 3 | 0.014 | |
| regulation of cellular protein metabolic process | GO:0032268 | 52 | 0.014 | |
| endosome to lysosome transport | GO:0008333 | 1 | 0.013 | |
| cellular response to external stimulus | GO:0071496 | 2 | 0.013 | |
| regulation of cytokine biosynthetic process | GO:0042035 | 1 | 0.013 | |
| establishment of localization | GO:0051234 | 244 | 0.013 | |
| negative regulation of biological process | GO:0048519 | 304 | 0.013 | |
| establishment of localization in cell | GO:0051649 | 77 | 0.013 | |
| negative regulation of signal transduction | GO:0009968 | 94 | 0.013 | |
| cellular amine metabolic process | GO:0044106 | 2 | 0.013 | |
| response to stress | GO:0006950 | 263 | 0.013 | |
| regulation of carbohydrate metabolic process | GO:0006109 | 4 | 0.013 | |
| cell cycle g1 s phase transition | GO:0044843 | 1 | 0.013 | |
| wound healing | GO:0042060 | 90 | 0.013 | |
| response to uv | GO:0009411 | 3 | 0.013 | |
| negative regulation of catabolic process | GO:0009895 | 3 | 0.013 | |
| nitrogen compound metabolic process | GO:0006807 | 319 | 0.013 | |
| negative regulation of cytokine mediated signaling pathway | GO:0001960 | 2 | 0.013 | |
| nucleobase containing compound metabolic process | GO:0006139 | 274 | 0.012 | |
| regulation of production of molecular mediator of immune response | GO:0002700 | 1 | 0.012 | |
| macromolecule modification | GO:0043412 | 111 | 0.012 | |
| macromolecule biosynthetic process | GO:0009059 | 227 | 0.012 | |
| regulation of endothelial cell proliferation | GO:0001936 | 1 | 0.012 | |
| compound eye development | GO:0048749 | 2 | 0.012 | |
| regulation of cell projection assembly | GO:0060491 | 4 | 0.012 | |
| cellular protein modification process | GO:0006464 | 100 | 0.012 | |
| regulation of hormone secretion | GO:0046883 | 2 | 0.012 | |
| negative regulation of immune response | GO:0050777 | 2 | 0.012 | |
| positive regulation of cellular process | GO:0048522 | 201 | 0.012 | |
| proteolysis | GO:0006508 | 38 | 0.012 | |
| phagosome maturation | GO:0090382 | 1 | 0.012 | |
| telomere organization | GO:0032200 | 1 | 0.012 | |
| regulation of protein catabolic process | GO:0042176 | 1 | 0.012 | |
| ovulation cycle | GO:0042698 | 2 | 0.012 | |
| p38mapk cascade | GO:0038066 | 1 | 0.012 | |
| erythrocyte homeostasis | GO:0034101 | 55 | 0.012 | |
| nucleobase containing compound biosynthetic process | GO:0034654 | 205 | 0.012 | |
| ovulation cycle process | GO:0022602 | 2 | 0.012 | |
| interaction with host | GO:0051701 | 4 | 0.011 | |
| regulation of tube size | GO:0035150 | 2 | 0.011 | |
| peptidyl lysine methylation | GO:0018022 | 3 | 0.011 | |
| apoptotic process | GO:0006915 | 116 | 0.011 | |
| cytokine metabolic process | GO:0042107 | 1 | 0.011 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 2 | 0.011 | |
| golgi organization | GO:0007030 | 1 | 0.011 | |
| organelle organization | GO:0006996 | 227 | 0.011 | |
| negative regulation of signaling | GO:0023057 | 96 | 0.011 | |
| cofactor biosynthetic process | GO:0051188 | 10 | 0.011 | |
| tetrapyrrole biosynthetic process | GO:0033014 | 8 | 0.011 | |
| regulation of protein import into nucleus | GO:0042306 | 2 | 0.011 | |
| regulation of i kappab kinase nf kappab signaling | GO:0043122 | 4 | 0.011 | |
| regulation of protein targeting | GO:1903533 | 2 | 0.011 | |
| positive regulation of blood circulation | GO:1903524 | 2 | 0.011 | |
| transport | GO:0006810 | 220 | 0.011 | |
| regulation of cytokine production | GO:0001817 | 3 | 0.011 | |
| response to topologically incorrect protein | GO:0035966 | 2 | 0.011 | |
| organic substance biosynthetic process | GO:1901576 | 289 | 0.011 | |
| positive regulation of stress activated protein kinase signaling cascade | GO:0070304 | 3 | 0.011 | |
| positive regulation of catabolic process | GO:0009896 | 4 | 0.011 | |
| regulation of blood vessel size | GO:0050880 | 2 | 0.011 | |
| oxoacid metabolic process | GO:0043436 | 31 | 0.011 | |
| somite development | GO:0061053 | 96 | 0.011 | |
| regulation of nitrogen compound metabolic process | GO:0051171 | 251 | 0.010 | |
| porphyrin containing compound metabolic process | GO:0006778 | 10 | 0.010 | |
| response to drug | GO:0042493 | 3 | 0.010 | |
| regulation of protein metabolic process | GO:0051246 | 56 | 0.010 | |
| establishment of protein localization to plasma membrane | GO:0090002 | 1 | 0.010 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 2 | 0.010 | |
| cytoplasm organization | GO:0007028 | 4 | 0.010 | |
| regulation of intracellular protein transport | GO:0033157 | 3 | 0.010 | |
| somitogenesis | GO:0001756 | 87 | 0.010 | |
| negative regulation of cell communication | GO:0010648 | 96 | 0.010 | |
| mitotic dna damage checkpoint | GO:0044773 | 4 | 0.010 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 3 | 0.010 | |
| regulation of extrinsic apoptotic signaling pathway | GO:2001236 | 3 | 0.010 | |
| positive regulation of cellular catabolic process | GO:0031331 | 3 | 0.010 | |
| organic cyclic compound biosynthetic process | GO:1901362 | 223 | 0.010 | |
| regulation of nucleotide catabolic process | GO:0030811 | 2 | 0.010 | |
| positive regulation of i kappab kinase nf kappab signaling | GO:0043123 | 3 | 0.010 | |
| regulation of p38mapk cascade | GO:1900744 | 1 | 0.010 | |
